Visiongain has published a new report on Addiction Treatment Market Report 2021-2031: Forecasts by Type (Tobacco/ Nicotine, Alcohol dependence, Marijuana, Synthetic Cannabinoids, Prescription and Over-the-Counter Medications, Drug abuse and Others), By Treatment Type (Nicotine Replacement Therapy, Psychological Therapy, Counseling and Behavioral Therapies, Rehabilitation programs, Psychotherapy and Others), By Drug Type (Approved-Drugs and Off-label Drugs), By Product Type (Patch, Gum, Pills, Lozenge, Spray and Others), By Route of Administration (Oral, Inhalation and Injectable), By End-User (Hospitals, Homecare, Specialty Clinics, Rehabilitation Treatment Centers and Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy, Ecommerce and Others). PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/addiction-treatment-market-2021/#download_sampe_div
COVID-19 Impact on Addiction Treatment Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Addiction Treatment market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:
Market Drivers
Increasing Consumptions of Tobacco Products
Consumptions of tobacco are significantly increasing and expected to continuously rise over the forecast period. The increase in the consumptions of tobacco creates a huge demand for the addiction treatment products giving an opportunity to the manufacturer to come up with innovative and cost effective product to cater the high demand. According to U.S. Department of Health & Human Services, 5.6 million of Americans younger than 18 will die early from a smoking-related illness.
Market Opportunities
Government Initiative and Awareness Program
Governments in various developed and developing nations are increasing their initiatives to increase awareness regarding repercussions associated with the consumption of tobacco/ nicotine, alcohol dependence, marijuana, synthetic cannabinoids, drug abuse consumption. Further, Governments and private authority across the developed & developing countries are focusing to increase the number of addiction treatment centres with new approval of addiction treatment drugs. For Instance: U.S. Department of Health & Human Services has launched tobacco control programs by featuring national and local campaigns and events, linking to state and community resources, producing guidelines, and compiling data.
Get Detailed TOC @ https://www.visiongain.com/report/addiction-treatment-market-2021/#download_sampe_div
Technological Advancements and the modernization in addiction treatment
Researchers and manufacturers from all over the world are increasing research and development activities for new advancements in the addiction treatment especially in tobacco/ nicotine, alcohol dependence, marijuana, synthetic cannabinoids, drug abuse helps to increase adoption of novel technologies in the addiction treatment arena. New research and development activities are expected to create competitive advantages by increasing advancements in the product which will create new opportunities in the market.
Competitive Landscape
Company's profile in the report include: – Mallinckrodt Plc., Hikma Pharmaceuticals plc, Orexo AB, Indivior PLC, Hager Biosciences, LLC, ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences, Inc., Astraea Therapeutics LLC, Altria Group, Inc., Johnson & Johnson Services, Inc., Novartis AG and Sanofi among others. Some of the key developments are listed below:
- In 2019, Omeros Corporation has published positive results from OMS527 program Phase 1 study, a inhibitors for the treatment of addictions. Through this development company will widened their market focused product portfolio.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Information found nowhere else
With our new report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Addiction Treatment Market and leading companies. You will find data, trends and predictions.
Find more Visiongain research reports on Therapeutic Drugs Sector click on the following links:
- Animal Vaccine Market
- Anticoagulants Market
- Antidiarrheal Drug Market
- Anti-acne Cosmetic Market
- Anti-neoplastic Agents Market
- Anti-snoring Treatment Market
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact:
Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.
